Will The Medicines Company be willing to charge significantly less than the price currently commanded by Repatha and Praluent?
from Forbes Real Time https://www.forbes.com/sites/johnlamattina/2017/10/26/the-medicine-companys-dangerous-bet-on-its-ldl-cholesterol-lowering-drug/
via IFTTT
No comments:
Post a Comment